Home » Topics » Regulatory

Regulatory
RSS

FDA approves Tecentriq for metastatic NSCLC

Oct. 19, 2016

FDA approves infant-specific dose of Pertzye

Oct. 13, 2016

FDA approves Carnexiv as intravenous short-term replacement therapy for seizures

Oct. 10, 2016

Micatrio approved in Japan for hypertension

Oct. 3, 2016

Mikeluna approved in Japan for glaucoma and intraocular hypertension

Sep. 30, 2016

FDA approves Orkambi for younger cystic fibrosis population

Sep. 29, 2016

FDA approves Rexulti labeling update for maintenance treatment of schizophrenia

Sep. 26, 2016

FDA approves adalimumab biosimilar Amjevita

Sep. 26, 2016

FDA grants accelerated approval to Exondys 51 for Duchenne muscular dystrophy

Sep. 20, 2016

FDA approves Aralez Pharmaceuticals' Yosprala

Sep. 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...